ABNORMAL LIPOPROTEIN AND APOLIPOPROTEIN PATTERN IN LIPOPROTEIN GLOMERULOPATHY

被引:61
作者
OIKAWA, S
SUZUKI, N
SAKUMA, E
SAITO, T
NAMAI, K
KOTAKE, H
FUJII, Y
TOYOTA, T
机构
[1] TOHOKU UNIV,SCH MED,DEPT INTERNAL MED 2,SENDAI,MIYAGI 980,JAPAN
[2] MIZUSAWA GEN HOSP,DEPT INTERNAL MED,MIZUSAWA,JAPAN
关键词
LIPOPROTEIN THROMBI; LIPOPROTEIN GLOMERULOPATHY; APOLIPOPROTEIN-E;
D O I
10.1016/S0272-6386(12)80649-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Recently, two cases of renal disease were observed in which there was an abnormal accumulation of lipids, “lipoprotein thrombi,” in the glomerular capillary lumen. This disease has been designated as lipoprotein glomerulopathy. Four other cases have been diagnosed independently by renal histology in other clinical laboratories. All six patients showed proteinuria (1.6 to 10 g/d), normal lecithin-cholesterol acyltransferase (LCAT) activity, type III hyperlipoproteinemia-like lipoprotein profiles, and significantly (P < 0.01) higher levels of plasma apolipoprotein (apo) E (>10 mg/dL) compared with the control patients with hyperlipidemic nephrotic syndrome without lipoprotein thrombi and type IIb hyperlipoproteinemia without renal disease. Lipoprotein glomerulopathy is not familial type III hyperlipoproteinemia (dysbetalipoproteinemia), because apolipoprotein E3 is present. Apo E isoforms were all rare: five cases of E2/3 and one case of E4/4. These results suggest that excessive apo E is associated with apo E isoform and lipoprotein metabolic derangement in such a renal disease. Further studies are needed on the relationship between the apo E hyperlipoproteinemia and the formation of lipoprotein thrombi. © 1991, National Kidney Foundation. All rights reserved.. All rights reserved.
引用
收藏
页码:553 / 558
页数:6
相关论文
共 35 条
[21]   APOLIPOPROTEIN-E PHENOTYPING FROM SERUM BY WESTERN BLOTTING [J].
MENZEL, HJ ;
UTERMANN, G .
ELECTROPHORESIS, 1986, 7 (11) :492-495
[22]  
MOORHEAD JF, 1982, LANCET, V2, P1309
[23]   BIOCHEMICAL, CLINICAL, AND GENETIC FEATURES OF TYPE-III HYPERLIPOPROTEINEMIA [J].
MORGANROTH, J ;
LEVY, RI ;
FREDRICKSON, DS .
ANNALS OF INTERNAL MEDICINE, 1975, 82 (02) :158-174
[24]   IDENTIFICATION OF A NEW STRUCTURAL VARIANT OF HUMAN APOLIPOPROTEIN-E, E2(LYS146-]GLN), IN A TYPE-III HYPERLIPOPROTEINEMIC SUBJECT WITH THE E3/2 PHENOTYPE [J].
RALL, SC ;
WEISGRABER, KH ;
INNERARITY, TL ;
BERSOT, TP ;
BLUM, CB ;
MAHLEY, RW .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 72 (04) :1288-1297
[25]   DIABETIC HYPERTRIGLYCERIDEMIA - EVIDENCE FOR 3 CLINICAL SYNDROMES [J].
REAVEN, GM ;
GREENFIELD, MS .
DIABETES, 1981, 30 :66-75
[26]   LIPOPROTEIN GLOMERULOPATHY - GLOMERULAR LIPOPROTEIN THROMBI IN A PATIENT WITH HYPERLIPOPROTEINEMIA [J].
SAITO, T ;
SATO, H ;
KUDO, K ;
OIKAWA, S ;
SHIBATA, T ;
HARA, Y ;
YOSHINAGA, K ;
SAKAGUCHI, H .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1989, 13 (02) :148-153
[27]  
SAKAGUCHI H, 1965, LAB INVEST, V14, P533
[28]   APOE-2/E-3 RATIO OF VERY LOW-DENSITY LIPOPROTEIN IN DIABETES-MELLITUS [J].
SANO, R ;
ABE, R ;
OIKAWA, S ;
FUJII, Y ;
TOYOTA, T .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 146 (02) :131-136
[29]  
SANO R, 1983, TOHOKU J EXP MED, V154, P297
[30]  
SHIBATA T, 1990, ACTA PATHOL JAPON, V40, P448